CLINTON RUSHING: Open Payments
NPI 1780070409 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,521 in 90 payments from 22 companies in 2025. Trend: 2023 $2,065 · 2024 $1,914 · 2025 $1,521
Food & beverage: $1,521
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $402 |
| ABBVIE INC. | 18 | $205 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $138 |
| Abbott Laboratories | 6 | $121 |
| PFIZER INC. | 6 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $73 |
| Janssen Pharmaceuticals, Inc | 3 | $62 |
| Astellas Pharma US Inc | 3 | $56 |
| Corcept Therapeutics | 3 | $56 |
| Amgen Inc. | 3 | $48 |
Products named: Ozempic, Wegovy, Kerendia, FREESTYLE LIBRE 3, UBRELVY, XIFAXAN, SPRAVATO, QULIPTA.
Industry payments across GA — which companies pay providers there.
